What is the management approach for sudden onset sensory neural hearing loss?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Sudden Onset Sensory Neural Hearing Loss

Oral corticosteroids should be initiated as first-line treatment for sudden sensorineural hearing loss (SSNHL) within 14 days of symptom onset, using prednisone 1 mg/kg/day (maximum 60 mg daily) for 10-14 days followed by a taper. 1

Diagnosis and Initial Evaluation

  • Confirm SSNHL through audiometric testing as soon as possible and within 14 days of symptom onset

    • SSNHL is defined as ≥30 dB hearing loss at 3 consecutive frequencies occurring over a 72-hour period 2, 1
    • Distinguish sensorineural from conductive hearing loss through tuning fork tests and physical examination 2
  • Perform a complete audiological evaluation including:

    • Pure-tone audiometry (1000-8000 Hz)
    • Speech audiometry to assess word recognition
    • Distortion product otoacoustic emissions to detect cochlear damage 1
  • Assess for red flags requiring urgent attention:

    • Bilateral hearing loss
    • Recurrent episodes
    • Focal neurologic findings 1

Treatment Algorithm

First-Line Treatment (within 14 days of onset)

  1. Oral corticosteroids:
    • Prednisone 1 mg/kg/day (maximum 60 mg daily) for 10-14 days, followed by a taper over a similar period 1
    • Do not divide doses 1
    • Monitor for adverse effects: sleep disturbances, weight gain, hypertension, and hyperglycemia (especially in diabetic patients) 1

Salvage Treatment (if incomplete recovery after initial therapy)

  1. Intratympanic steroid therapy (2-6 weeks after onset):

    • Options include:
      • Dexamethasone 24 mg/mL (compounded) or 10 mg/mL (stock)
      • Methylprednisolone 40 mg/mL or 30 mg/mL
    • Administration: 0.4-0.8 mL injected into middle ear space, 2-3 times per week for 2 weeks (up to 4 injections) 2, 1
    • Patients should remain with affected ear up for 15-30 minutes after injection 1
  2. Hyperbaric oxygen therapy (HBOT):

    • May be offered in conjunction with steroids within 2 weeks of diagnosis or up to 1 month after onset 2, 1
    • Particularly beneficial for younger patients (under 50-60 years) with moderate to severe hearing loss (>60 dB) 1

Combination Therapy

  • Consider combination of oral and intratympanic steroids for patients with severe to profound hearing loss 1
  • Research shows that adding intratympanic steroids to systemic steroids may provide additional benefit, though the optimal timing remains under investigation 3

Treatments to Avoid

  • Do NOT routinely prescribe:

    • Antivirals
    • Thrombolytics
    • Vasodilators
    • Vasoactive substances 2, 1
  • Do NOT order:

    • Routine head CT scans (non-targeted) 2
    • Routine laboratory tests 2

Imaging and Further Workup

  • MRI is recommended to rule out retrocochlear pathology (e.g., vestibular schwannoma) 2
  • If MRI cannot be performed, CT scan or auditory brainstem response evaluation are secondary options 2

Follow-up and Rehabilitation

  • Obtain audiometric evaluation:

    • At the conclusion of treatment
    • Within 6 months of completing treatment 2, 1
  • For patients with residual hearing loss and/or tinnitus:

    • Provide audiologic rehabilitation options
    • Consider hearing aids, cochlear implants, or hearing-assistive technology 1

Prognosis

  • Without treatment, spontaneous recovery occurs in 32-65% of cases 1
  • Most recovery occurs within 1 month (78% of patients) and by 3 months (97% of patients) 1
  • Early intervention is critical for better outcomes 1
  • Factors associated with poorer prognosis:
    • Older age
    • Presence of vertigo
    • Greater degree of initial hearing loss 4

Clinical Considerations

  • Approximately 90% of SSNHL cases are idiopathic at presentation 2
  • Evidence from comparative studies shows that intratympanic steroids are not inferior to oral steroids as primary treatment 5, but oral steroids remain the standard first-line approach due to ease of administration
  • For patients with contraindications to systemic steroids (diabetes, hypertension, glaucoma, tuberculosis, peptic ulcer disease, prior psychiatric reactions), intratympanic steroids may be considered as primary therapy 1

Remember that prompt recognition and early intervention within 14 days of symptom onset is crucial for maximizing hearing recovery and improving quality of life.

References

Guideline

Sudden Sensorineural Hearing Loss Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Evaluation of Sudden Sensory-Neural Hearing Loss Patients Treated with Systemic Steroids with Additional Intratympanic Dexamethasone Injection in Different Intervals; a Clinical Trial Study.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2023

Research

Efficacy of oral vs. intratympanic corticosteroids in sudden sensorineural hearing loss.

Journal of basic and clinical physiology and pharmacology, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.